-
1
-
-
33947246636
-
Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo
-
M Huang H Gao Y Chen H Zhu Y Cai X Zhang Z Miao H Jiang J Zhang H Shen L Lin W Lu J Ding 2007 Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo Clin Cancer Res 13 1298 1307
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1298-1307
-
-
Huang, M.1
Gao, H.2
Chen, Y.3
Zhu, H.4
Cai, Y.5
Zhang, X.6
Miao, Z.7
Jiang, H.8
Zhang, J.9
Shen, H.10
Lin, L.11
Lu, W.12
Ding, J.13
-
2
-
-
20944436253
-
Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms
-
MG Song SM Gao KM Du M Xu Y Yu YH Zhou Q Wang Z Chen YS Zhu GQ Chen 2005 Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms Blood 105 3714 3721
-
(2005)
Blood
, vol.105
, pp. 3714-3721
-
-
Song, M.G.1
Gao, S.M.2
Du, K.M.3
Xu, M.4
Yu, Y.5
Zhou, Y.H.6
Wang, Q.7
Chen, Z.8
Zhu, Y.S.9
Chen, G.Q.10
-
3
-
-
0033564494
-
Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties
-
L Lesueur-Ginot D Demarquay R Kiss PG Kasprzyk L Dassonneville C Bailly J Camara O Lavergne DC Bigg 1999 Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties Cancer Res 59 2939 2943
-
(1999)
Cancer Res
, vol.59
, pp. 2939-2943
-
-
Lesueur-Ginot, L.1
Demarquay, D.2
Kiss, R.3
Kasprzyk, P.G.4
Dassonneville, L.5
Bailly, C.6
Camara, J.7
Lavergne, O.8
Bigg, D.C.9
-
4
-
-
0035476245
-
Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin
-
MD Cesare G Pratesi P Perego N Carenini S Tinell L Merlini S Penco 2001 Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin Cancer Res 61 7189 7195
-
(2001)
Cancer Res
, vol.61
, pp. 7189-7195
-
-
Cesare, M.D.1
Pratesi, G.2
Perego, P.3
Carenini, N.4
Tinell, S.5
Merlini, L.6
Penco, S.7
-
6
-
-
5644264888
-
Gefitinib enhances the antitumor activity and oral bioavailability of Irinotecan in mice
-
CF Stewart M Leggas JD Schuetz JC Panetta PJ Cheshire J Peterson N Daw JJ Jenkins 3rd R Gilbertson GS Germain FC Harwood PJ Houghton 2004 Gefitinib enhances the antitumor activity and oral bioavailability of Irinotecan in mice Cancer Res 64 7491 7499
-
(2004)
Cancer Res
, vol.64
, pp. 7491-7499
-
-
Stewart, C.F.1
Leggas, M.2
Schuetz, J.D.3
Panetta, J.C.4
Cheshire, P.J.5
Peterson, J.6
Daw, N.7
Jenkins III, J.J.8
Gilbertson, R.9
Germain, G.S.10
Harwood, F.C.11
Houghton, P.J.12
-
7
-
-
17644416399
-
Tirapazamine cytotoxicity for neuroblastoma is p53 dependent
-
B Yang CP Reynolds 2005 Tirapazamine cytotoxicity for neuroblastoma is p53 dependent Clin Cancer Res 11 2774 2780
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2774-2780
-
-
Yang, B.1
Reynolds, C.P.2
-
8
-
-
0033564494
-
Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase i-targeted activity and antitumor properties
-
L Lesueur-Ginot D Demarquay R Kiss PG Kasprzyk L Dassonneville C Bailly J Camara O Lavergne DC Bigg 1999 Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase i-targeted activity and antitumor properties Cancer Res 59 2939 2943
-
(1999)
Cancer Res
, vol.59
, pp. 2939-2943
-
-
Lesueur-Ginot, L.1
Demarquay, D.2
Kiss, R.3
Kasprzyk, P.G.4
Dassonneville, L.5
Bailly, C.6
Camara, J.7
Lavergne, O.8
Bigg, D.C.9
-
9
-
-
12444297898
-
Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts
-
G Petrangolini G Pratesi M De Cesare R Supino C Pisano M Marcellini V Giordano D Laccabue C Lanzi F Zunino 2003 Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts Mol Cancer Res 1 863 870
-
(2003)
Mol Cancer Res
, vol.1
, pp. 863-870
-
-
Petrangolini, G.1
Pratesi, G.2
De Cesare, M.3
Supino, R.4
Pisano, C.5
Marcellini, M.6
Giordano, V.7
Laccabue, D.8
Lanzi, C.9
Zunino, F.10
-
10
-
-
0030014783
-
DNA topoisomerases
-
JC Wang 1996 DNA topoisomerases Annu Rev Biochem 65 635 692
-
(1996)
Annu Rev Biochem
, vol.65
, pp. 635-692
-
-
Wang, J.C.1
-
11
-
-
0036085460
-
Cellular roles of DNA topoisomerases: A molecular perspective
-
JC Wang 2002 Cellular roles of DNA topoisomerases: a molecular perspective Nat Rev Mol Cell Biol 3 430 440
-
(2002)
Nat Rev Mol Cell Biol
, vol.3
, pp. 430-440
-
-
Wang, J.C.1
-
12
-
-
0034923502
-
DNA topoisomerases: Structure, function, and mechanism
-
JJ Champoux 2001 DNA topoisomerases: structure, function, and mechanism Annu Rev Biochem 70 369 413
-
(2001)
Annu Rev Biochem
, vol.70
, pp. 369-413
-
-
Champoux, J.J.1
-
13
-
-
0033663604
-
Topoisomerase I-mediated DNA damage
-
P Pourquier Y Pommier 2001 Topoisomerase I-mediated DNA damage Adv Cancer Res 80 189 216
-
(2001)
Adv Cancer Res
, vol.80
, pp. 189-216
-
-
Pourquier, P.1
Pommier, Y.2
-
15
-
-
0036491204
-
P53: An internal investigation
-
IL Hayon Y Haupt 2002 p53: an internal investigation Cell Cycle 1 111 116
-
(2002)
Cell Cycle
, vol.1
, pp. 111-116
-
-
Hayon, I.L.1
Haupt, Y.2
-
17
-
-
0034616946
-
Apoptotic pathways: Paper wraps stone blunts scissors
-
DR Green 2000 Apoptotic pathways: paper wraps stone blunts scissors Cell 102 1 4
-
(2000)
Cell
, vol.102
, pp. 1-4
-
-
Green, D.R.1
-
18
-
-
0030979773
-
Double identity for proteins of the Bcl-2 family
-
JC Reed 1997 Double identity for proteins of the Bcl-2 family Nature (Lond.) 387 773 776
-
(1997)
Nature (Lond.)
, vol.387
, pp. 773-776
-
-
Reed, J.C.1
-
19
-
-
33645059697
-
The small organic compound HA14-1 prevents Bcl-2 interaction with bax to sensitize malignant glioma cells to induction of cell death
-
F Manero F Gautier T Gallenne N Cauquil D Grée PF Cartron O Geneste R Grée FM Vallette P Juin 2006 The small organic compound HA14-1 prevents Bcl-2 interaction with bax to sensitize malignant glioma cells to induction of cell death Cancer Res 66 2757 2764
-
(2006)
Cancer Res
, vol.66
, pp. 2757-2764
-
-
Manero, F.1
Gautier, F.2
Gallenne, T.3
Cauquil, N.4
Grée, D.5
Cartron, P.F.6
Geneste, O.7
Grée, R.8
Vallette, F.M.9
Juin, P.10
-
21
-
-
33745685904
-
Mitogen-activated protein kinase phosphatase 2: A novel transcription target of p53 in apoptosis
-
WH Shen J Wang JJ Wu VB Zhurkin YX Yin 2006 Mitogen-activated protein kinase phosphatase 2: a novel transcription target of p53 in apoptosis Cancer Res 66 6033 6039
-
(2006)
Cancer Res
, vol.66
, pp. 6033-6039
-
-
Shen, W.H.1
Wang, J.2
Wu, J.J.3
Zhurkin, V.B.4
Yin, Y.X.5
-
22
-
-
0034607702
-
Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
-
C Tournier P Hess DD Yang J Xu TK Turner A Nimnual D Bar-Sagi SN Jones RA Flavell RJ Davis 2000 Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288 870 874
-
(2000)
Science
, vol.288
, pp. 870-874
-
-
Tournier, C.1
Hess, P.2
Yang, D.D.3
Xu, J.4
Turner, T.K.5
Nimnual, A.6
Bar-Sagi, D.7
Jones, S.N.8
Flavell, R.A.9
Davis, R.J.10
-
23
-
-
1542615077
-
A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: Involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation
-
N Miyoshi K Uchida T Osawa Y Nakamura 2004 A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation Cancer Res 64 2134 2142
-
(2004)
Cancer Res
, vol.64
, pp. 2134-2142
-
-
Miyoshi, N.1
Uchida, K.2
Osawa, T.3
Nakamura, Y.4
-
24
-
-
0034710303
-
P38 MAP kinase mediates bax translocation in nitric oxide induced apoptosis in neurons
-
S Ghatan S Larner Y Kinoshita M Hetman L Patel Z Xia RJ Youle RS Morrison 2000 p38 MAP kinase mediates bax translocation in nitric oxide induced apoptosis in neurons J Cell Biol 150 335 347
-
(2000)
J Cell Biol
, vol.150
, pp. 335-347
-
-
Ghatan, S.1
Larner, S.2
Kinoshita, Y.3
Hetman, M.4
Patel, L.5
Xia, Z.6
Youle, R.J.7
Morrison, R.S.8
-
26
-
-
0032562704
-
Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha
-
A Roulston C Reinhard P Amiri LT Williams 1998 Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha J Biol Chem 273 10232 10239
-
(1998)
J Biol Chem
, vol.273
, pp. 10232-10239
-
-
Roulston, A.1
Reinhard, C.2
Amiri, P.3
Williams, L.T.4
-
27
-
-
0034278085
-
The IAP family: Endogenous caspase inhibitors with multiple biological activities
-
YL Yang XM Li 2000 The IAP family: endogenous caspase inhibitors with multiple biological activities Cell Res 10 169 177
-
(2000)
Cell Res
, vol.10
, pp. 169-177
-
-
Yang, Y.L.1
Li, X.M.2
-
28
-
-
2342615480
-
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells
-
JM Cummins M Kohli C Rago KW Kinzler B Vogelstein F Bunz 2004 X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells Cancer Res 64 3006 3008
-
(2004)
Cancer Res
, vol.64
, pp. 3006-3008
-
-
Cummins, J.M.1
Kohli, M.2
Rago, C.3
Kinzler, K.W.4
Vogelstein, B.5
Bunz, F.6
|